Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BOSTON SCIENTIFIC CORPBSX · Entity 1897 | Director | October 01, 2020 | October 05, 2020 |
| ILLUMINA, INC.ILMN · Entity 3137 | Director | May 16, 2024 | May 17, 2024 |
| STRYKER CORPSYK · Entity 369 | President & CEO | February 06, 2012 | February 08, 2012 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BOSTON SCIENTIFIC CORP
Report date October 01, 2020 · Filed October 05, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 8,000 |
Reported balance
After 2020-10-01 transaction · row 1
1 source rowRow 1 · 2020-10-01 · Grant · Acquired 498 · Balance 8,000 F1: Restricted stock granted in lieu of cash compensation, vesting in full upon the next annual meeting of stockholders. Reflects a value of $19,167, divided by the closing price of common stock on the date of grant. This grant represents the equivalent of two months of the board cash retainer as a result of board approval of the restoration of a portion of its cash compensation as disclosed on a Form 8-K dated October 5, 2020. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock granted in lieu of cash compensation, vesting in full upon the next annual meeting of stockholders. Reflects a value of $19,167, divided by the closing price of common stock on the date of grant. This grant represents the equivalent of two months of the board cash retainer as a result of board approval of the restoration of a portion of its cash compensation as disclosed on a Form 8-K dated October 5, 2020.
ILLUMINA, INC.
Report date May 16, 2024 · Filed May 17, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,129 |
Reported balance
After 2024-05-16 transaction · row 1
1 source rowRow 1 · 2024-05-16 · Grant · Acquired 2,622 · Balance 4,129 F1: Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's stockholders for the year following the year of grant of the award, provided, in each case, that the awardee continues to serve as a director on such date. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's stockholders for the year following the year of grant of the award, provided, in each case, that the awardee continues to serve as a director on such date.
STRYKER CORP
Report date February 06, 2012 · Filed February 08, 2012
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 132,002 |
Reported balance
After 2012-02-06 transaction · row 1
1 source rowRow 1 · 2012-02-06 · Exercise / conversion · Acquired 5,000 · Balance 132,002 |
| Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $46.85 · Expires 2016-02-06 | Direct | 0 |
Reported balance
After 2012-02-06 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2012-02-06 · Exercise / conversion · Disposed 5,000 · Balance 0 F1: Employee stock option granted pursuant to the Stryker Corporation 1998 Stock Option Plan, exercisable as to 10% on each of the first eight anniversaries of the date of grant and 20% on the ninth anniversary of the date of grant. |
| Common StockSEC Table I · non-derivative | IndirectBy 401k Plan | 716 |
Reported balance
Holding disclosure · report date 2012-02-06 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 716 |
| Common StockSEC Table I · non-derivative | IndirectAs Custodian | 200 |
Reported balance
Holding disclosure · report date 2012-02-06 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 200 |
Filing footnotes · ownership attribution and instrument terms
F1: Employee stock option granted pursuant to the Stryker Corporation 1998 Stock Option Plan, exercisable as to 10% on each of the first eight anniversaries of the date of grant and 20% on the ninth anniversary of the date of grant.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
HOLOGIC INC
Report date April 07, 2026 · Filed April 09, 2026
Section 16 reporting ended · disclosed 2026-04-09. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2026-04-07 transaction · row 1
1 source rowRow 1 · 2026-04-07 · Disposition to issuer · Disposed 1,423,837 · Balance 0 F1: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to Hologic's Deferred Equity Plan. F2: Pursuant to the Agreement and Plan of Merger, dated as of October 21, 2025 (the "Merger Agreement"), by and among Hologic, Inc. ("Hologic" or "Company"), Hopper Parent Inc., a Delaware corporation ("Parent"), and Hopper Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Company (the "Merger"), with the Company surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each share of Hologic common stock, par value $0.01 ("Company Common Stock"), was converted into the right to receive (x) $76.00 per share in cash, without interest (the "Cash Consideration") and (y) one (1) contingent value right, which represents the right to receive up to $3.00 in cash, when and if payable (each, a "CVR") (the consideration contemplated by clauses (x) and (y), together, the "Merger Consideration"). F3: At the Effective Time, each time-vesting restricted stock unit award ("Company RSU") held by the reporting person granted before October 21, 2025 converted into the right to receive the Merger Consideration for each share of Company Common Stock underlying the Company RSU; and each Company RSU held by the reporting person granted after October 21, 2025 converted into, for each share of Company Common Stock subject to such Company RSU immediately prior to the Effective Time, (i) an unvested award representing the right to receive a cash payment equal to the Cash Consideration, and (ii) an unvested award representing the right to receive cash payments equal to the payments to the holder of one CVR, if any, pursuant to the CVR agreement, in each case, subject to the terms applied to the corresponding Company RSU immediately prior to the Effective Time. As a result of the Merger, the reporting person no longer beneficially owns, directly or indirectly, any shares of Company Common Stock. |
| Common StockSEC Table I · non-derivative | IndirectMacMillan Family Trust | 0 |
Reported balance
After 2026-04-07 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2026-04-07 · Disposition to issuer · Disposed 1,146,829 · Balance 0 F2: Pursuant to the Agreement and Plan of Merger, dated as of October 21, 2025 (the "Merger Agreement"), by and among Hologic, Inc. ("Hologic" or "Company"), Hopper Parent Inc., a Delaware corporation ("Parent"), and Hopper Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Company (the "Merger"), with the Company surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each share of Hologic common stock, par value $0.01 ("Company Common Stock"), was converted into the right to receive (x) $76.00 per share in cash, without interest (the "Cash Consideration") and (y) one (1) contingent value right, which represents the right to receive up to $3.00 in cash, when and if payable (each, a "CVR") (the consideration contemplated by clauses (x) and (y), together, the "Merger Consideration"). F4: As a result of the Merger, the reporting person no longer beneficially owns, directly or indirectly, any shares of Company Common Stock. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $37.64 · Expires 2026-12-01 | Direct | 0 |
Reported balance
After 2026-04-07 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-04-07 · Disposition to issuer · Disposed 160,565 · Balance 0 F5: For Footnote (5), see Remarks below. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $40.85 · Expires 2027-12-01 | Direct | 0 |
Reported balance
After 2026-04-07 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-04-07 · Disposition to issuer · Disposed 159,339 · Balance 0 F5: For Footnote (5), see Remarks below. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $40.85 · Expires 2027-12-01 | Direct | 0 |
Reported balance
After 2026-04-07 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-04-07 · Disposition to issuer · Disposed 768,639 · Balance 0 F5: For Footnote (5), see Remarks below. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $40.97 · Expires 2028-11-12 | Direct | 0 |
Reported balance
After 2026-04-07 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-04-07 · Disposition to issuer · Disposed 151,071 · Balance 0 F5: For Footnote (5), see Remarks below. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $45.61 · Expires 2029-11-11 | Direct | 0 |
Reported balance
After 2026-04-07 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-04-07 · Disposition to issuer · Disposed 152,529 · Balance 0 F5: For Footnote (5), see Remarks below. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $68.35 · Expires 2030-11-09 | Direct | 0 |
Reported balance
After 2026-04-07 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-04-07 · Disposition to issuer · Disposed 123,801 · Balance 0 F5: For Footnote (5), see Remarks below. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $71.13 · Expires 2031-11-08 | Direct | 0 |
Reported balance
After 2026-04-07 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2026-04-07 · Disposition to issuer · Disposed 118,877 · Balance 0 F5: For Footnote (5), see Remarks below. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $74.35 · Expires 2032-11-07 | Direct | 0 |
Reported balance
After 2026-04-07 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2026-04-07 · Disposition to issuer · Disposed 106,300 · Balance 0 F5: For Footnote (5), see Remarks below. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $71.94 · Expires 2033-11-14 | Direct | 0 |
Reported balance
After 2026-04-07 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2026-04-07 · Disposition to issuer · Disposed 117,829 · Balance 0 F5: For Footnote (5), see Remarks below. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $79.39 · Expires 2034-11-11 | Direct | 0 |
Reported balance
After 2026-04-07 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2026-04-07 · Disposition to issuer · Disposed 117,801 · Balance 0 F5: For Footnote (5), see Remarks below. |
| Performance Stock UnitsSEC Table II · derivative / convertible security | Direct | 190,400 |
Reported balance
After 2026-04-07 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2026-04-07 · Grant · Acquired 190,400 · Balance 190,400 F6: Each Hologic restricted stock unit represents a contingent right to receive one share of Company Common Stock. F7: Represents the certification of performance results applicable to outstanding Hologic performance stock units ("PSUs") by the compensation committee of the board of directors of Hologic. Pursuant to the Merger Agreement, for purposes of determining the number of shares of Company Common Stock subject to each PSU, any applicable performance goals were deemed achieved at the greater of (A) the target level of performance and (B) the actual level of performance measured through the latest practicable date prior to the Effective Time. Pursuant to the Merger Agreement, each outstanding PSU was cancelled and converted into the right to receive the Merger Consideration in respect of each share of Company Common Stock subject to such PSU. |
| Performance Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-04-07 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2026-04-07 · Disposition to issuer · Disposed 190,400 · Balance 0 F6: Each Hologic restricted stock unit represents a contingent right to receive one share of Company Common Stock. F7: Represents the certification of performance results applicable to outstanding Hologic performance stock units ("PSUs") by the compensation committee of the board of directors of Hologic. Pursuant to the Merger Agreement, for purposes of determining the number of shares of Company Common Stock subject to each PSU, any applicable performance goals were deemed achieved at the greater of (A) the target level of performance and (B) the actual level of performance measured through the latest practicable date prior to the Effective Time. Pursuant to the Merger Agreement, each outstanding PSU was cancelled and converted into the right to receive the Merger Consideration in respect of each share of Company Common Stock subject to such PSU. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to Hologic's Deferred Equity Plan.
F2: Pursuant to the Agreement and Plan of Merger, dated as of October 21, 2025 (the "Merger Agreement"), by and among Hologic, Inc. ("Hologic" or "Company"), Hopper Parent Inc., a Delaware corporation ("Parent"), and Hopper Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Company (the "Merger"), with the Company surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each share of Hologic common stock, par value $0.01 ("Company Common Stock"), was converted into the right to receive (x) $76.00 per share in cash, without interest (the "Cash Consideration") and (y) one (1) contingent value right, which represents the right to receive up to $3.00 in cash, when and if payable (each, a "CVR") (the consideration contemplated by clauses (x) and (y), together, the "Merger Consideration").
F3: At the Effective Time, each time-vesting restricted stock unit award ("Company RSU") held by the reporting person granted before October 21, 2025 converted into the right to receive the Merger Consideration for each share of Company Common Stock underlying the Company RSU; and each Company RSU held by the reporting person granted after October 21, 2025 converted into, for each share of Company Common Stock subject to such Company RSU immediately prior to the Effective Time, (i) an unvested award representing the right to receive a cash payment equal to the Cash Consideration, and (ii) an unvested award representing the right to receive cash payments equal to the payments to the holder of one CVR, if any, pursuant to the CVR agreement, in each case, subject to the terms applied to the corresponding Company RSU immediately prior to the Effective Time. As a result of the Merger, the reporting person no longer beneficially owns, directly or indirectly, any shares of Company Common Stock.
F4: As a result of the Merger, the reporting person no longer beneficially owns, directly or indirectly, any shares of Company Common Stock.
F5: For Footnote (5), see Remarks below.
F6: Each Hologic restricted stock unit represents a contingent right to receive one share of Company Common Stock.
F7: Represents the certification of performance results applicable to outstanding Hologic performance stock units ("PSUs") by the compensation committee of the board of directors of Hologic. Pursuant to the Merger Agreement, for purposes of determining the number of shares of Company Common Stock subject to each PSU, any applicable performance goals were deemed achieved at the greater of (A) the target level of performance and (B) the actual level of performance measured through the latest practicable date prior to the Effective Time. Pursuant to the Merger Agreement, each outstanding PSU was cancelled and converted into the right to receive the Merger Consideration in respect of each share of Company Common Stock subject to such PSU.
TEXAS INSTRUMENTS INC
Report date February 17, 2012 · Filed February 21, 2012
Section 16 reporting ended · disclosed 2012-02-21. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $1.00 | Direct | 5,899.25 |
Reported balance
After 2012-02-17 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2012-02-17 · Grant · Acquired 98.3 · Balance 5,899.25 F1: Security converts to common stock on a one-for-one basis. F2: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. |
| Common StockSEC Table I · non-derivative | Direct | 13,977 |
Reported balance
Holding disclosure · report date 2012-02-17 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 13,977 |
Filing footnotes · ownership attribution and instrument terms
F1: Security converts to common stock on a one-for-one basis.
F2: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 06, 2023 Filed Nov 8, 2023 22:17 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantCommon Stock | 24,133 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-23-027047 · form4.xml · nonDerivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,273,483 F1 · shares: Represents performance stock units as to which the performance criteria has been satisfied but which remain subject to service-based vesting requirements. F2 · price: Performance stock units are settled in shares of common stock on a one-for-one basis. F3 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| August 30, 2023 Filed Sep 1, 2023 20:07 UTC | HOLOGIC INC HOLX · Entity 12463 | GiftCommon Stock | 1,064,954 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-023567 · form4.xml · nonDerivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,249,350 F1 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. F2 · balance_after: Includes 334 shares acquired pursuant to the Issuer's employee stock purchase plan since the date of the Reporting Person's most recently filed Form 4. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 21:02 UTC | ILLUMINA, INC. ILMN · Entity 3137 | GrantCommon Stock | 1,507 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-017872 · form4.xml · nonDerivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,507 F1 · shares: Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's stockholders for the year following the year of grant of the award, provided, in each case, that the awardee continues to serve as a director on such date. Read SEC document |
| November 30, 2022 Filed Dec 2, 2022 21:12 UTC | HOLOGIC INC HOLX · Entity 12463 | SaleCommon Stock | 12,501 | $76.02 | $950,326.02 |
DisclosureSEC source: 0001127602-22-026759 · form4.xml · nonDerivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,313,970 F3 · price: The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $75.80 to $76.17 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price. F2 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| November 30, 2022 Filed Dec 2, 2022 21:12 UTC | HOLOGIC INC HOLX · Entity 12463 | SaleCommon Stock | 20,999 | $75.43 | $1,584,038.57 |
DisclosureSEC source: 0001127602-22-026759 · form4.xml · nonDerivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,326,471 F1 · price: The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $75.00 to $75.77 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price. F2 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| November 11, 2022 Filed Nov 14, 2022 21:52 UTC | HOLOGIC INC HOLX · Entity 12463 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 95,422 | $0.00 Strike: $26.21 | $0.00 |
DisclosureSEC source: 0001127602-22-025510 · form4.xml · derivative · entry 7 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,422 Underlying: Common Stock · 95,422 shares Expires 2024-11-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This option to purchase common stock became exercisable in equal installments on each of the first five anniversaries of the grant date, November 7, 2014. Read SEC document |
| November 11, 2022 Filed Nov 14, 2022 21:52 UTC | HOLOGIC INC HOLX · Entity 12463 | Tax withholdingCommon Stock | 96,355 | $75.93 | $7,316,235.15 |
DisclosureSEC source: 0001127602-22-025510 · form4.xml · nonDerivative · entry 6 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,347,470 F1 · shares: Shares withheld for tax obligations in connection with the settlement of restricted stock units/performance stock units for which service-based vesting requirements have been satisfied. F2 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| November 11, 2022 Filed Nov 14, 2022 21:52 UTC | HOLOGIC INC HOLX · Entity 12463 | SaleCommon Stock | 42,893 | $75.94 | $3,257,294.42 |
DisclosureSEC source: 0001127602-22-025510 · form4.xml · nonDerivative · entry 5 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,443,825 F5 · price: The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $75.94 to $76.07 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price. F2 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| November 11, 2022 Filed Nov 14, 2022 21:52 UTC | HOLOGIC INC HOLX · Entity 12463 | SaleCommon Stock | 52,529 | $75.57 | $3,969,564.00 |
DisclosureSEC source: 0001127602-22-025510 · form4.xml · nonDerivative · entry 4 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,486,718 F4 · price: The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $75.00 to $75.935 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price. F2 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| November 11, 2022 Filed Nov 14, 2022 21:52 UTC | HOLOGIC INC HOLX · Entity 12463 | Exercise / conversionCommon Stock | 95,422 | $26.21 | $2,501,010.62 |
DisclosureSEC source: 0001127602-22-025510 · form4.xml · nonDerivative · entry 3 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,539,247 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| November 11, 2022 Filed Nov 14, 2022 21:52 UTC | HOLOGIC INC HOLX · Entity 12463 | SaleCommon Stock | 43,000 | $75.64 | $3,252,520.00 |
DisclosureSEC source: 0001127602-22-025510 · form4.xml · nonDerivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,443,825 F3 · price: The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $75.00 to $76.00 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price. F2 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| November 09, 2022 Filed Nov 14, 2022 21:52 UTC | HOLOGIC INC HOLX · Entity 12463 | Tax withholdingCommon Stock | 5,776 | $72.11 | $416,507.36 |
DisclosureSEC source: 0001127602-22-025510 · form4.xml · nonDerivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,486,825 F1 · shares: Shares withheld for tax obligations in connection with the settlement of restricted stock units/performance stock units for which service-based vesting requirements have been satisfied. F2 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| November 08, 2022 Filed Nov 9, 2022 22:09 UTC | HOLOGIC INC HOLX · Entity 12463 | Tax withholdingCommon Stock | 4,052 | $73.71 | $298,672.92 |
DisclosureSEC source: 0001127602-22-025215 · form4.xml · nonDerivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,492,601 F3 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. F4 · balance_after: Includes 326 shares acquired pursuant to the Issuer's employee stock purchase plan since the date of the Reporting Person's most recently filed Form 4. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 22:09 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantNon-qualified Stock Option (Right to Buy) · Derivative | 106,300 | $0.00 Strike: $74.35 | $0.00 |
DisclosureSEC source: 0001127602-22-025215 · form4.xml · derivative · entry 3 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,300 Underlying: Common Stock · 106,300 shares Expires 2032-11-07 F5 · derivative.exercise_date: This option to purchase common stock becomes exercisable in equal installments on each of the first four anniversaries of the grant date, November 7, 2022. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 22:09 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantCommon Stock | 36,987 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-025215 · form4.xml · nonDerivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,496,653 F1 · shares: Represents restricted stock units which vest in equal installments on each of the first three anniversaries of the grant date, November 7, 2022. F2 · price: Restricted stock units are settled in shares of common stock on a one-for-one basis. F3 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. F4 · balance_after: Includes 326 shares acquired pursuant to the Issuer's employee stock purchase plan since the date of the Reporting Person's most recently filed Form 4. Read SEC document |
| November 01, 2022 Filed Nov 3, 2022 20:52 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantCommon Stock | 103,447 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-024919 · form4.xml · nonDerivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,459,666 F1 · shares: Represents performance stock units as to which the performance criteria has been satisfied but which remain subject to service-based vesting requirements. F2 · price: Performance stock units are settled in shares of common stock on a one-for-one basis. F3 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. F4 · balance_after: Includes 326 shares acquired pursuant to the Issuer's employee stock purchase plan since the date of the Reporting Person's most recently filed Form 4. Read SEC document |
| November 12, 2021 Filed Nov 15, 2021 21:27 UTC | HOLOGIC INC HOLX · Entity 12463 | Tax withholdingCommon Stock | 91,777 | $73.54 | $6,749,280.58 |
DisclosureSEC source: 0001127602-21-029122 · form4.xml · nonDerivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,355,893 F1 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| November 11, 2021 Filed Nov 15, 2021 21:27 UTC | HOLOGIC INC HOLX · Entity 12463 | Tax withholdingCommon Stock | 7,345 | $72.61 | $533,320.45 |
DisclosureSEC source: 0001127602-21-029122 · form4.xml · nonDerivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,447,670 F1 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| November 09, 2021 Filed Nov 10, 2021 21:40 UTC | HOLOGIC INC HOLX · Entity 12463 | Tax withholdingCommon Stock | 4,173 | $71.26 | $297,367.98 |
DisclosureSEC source: 0001127602-21-028827 · form4.xml · nonDerivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,455,015 F3 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 21:40 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantNon-qualified Stock Option (Right to Buy) · Derivative | 118,877 | $0.00 Strike: $71.13 | $0.00 |
DisclosureSEC source: 0001127602-21-028827 · form4.xml · derivative · entry 3 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,877 Underlying: Common Stock · 118,877 shares Expires 2031-11-08 F4 · derivative.exercise_date: This option to purchase common stock becomes exercisable in equal installments on each of the first four anniversaries of the grant date, November 8, 2021. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 21:40 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantCommon Stock | 35,146 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-028827 · form4.xml · nonDerivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,459,188 F1 · shares: Represents restricted stock units which vest in equal installments on each of the first three anniversaries of the grant date, November 8, 2021. F2 · price: Restricted stock units are settled in shares of common stock on a one-for-one basis. F3 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 20:36 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantCommon Stock | 240,732 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-028297 · form4.xml · nonDerivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,424,042 F1 · shares: Represents performance stock units as to which the performance criteria has been satisfied but which remain subject to service-based vesting requirements. F2 · price: Performance stock units are settled in shares of common stock on a one-for-one basis. F3 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. F4 · balance_after: Includes 343 shares acquired pursuant to the Issuer's employee stock purchase plan since the date of the Reporting Person's most recently filed Form 4. Read SEC document |
| February 05, 2021 Filed Oct 20, 2021 20:29 UTC | HOLOGIC INC HOLX · Entity 12463 | GiftCommon Stock | 5,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-027388 · form5.xml · nonDerivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,182,967 F2 · kind: The transactions reported represent gifts by the reporting person to create and fund Davidson College's first fully endowed athletic scholarship program. F3 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 22:13 UTC | HOLOGIC INC HOLX · Entity 12463 | Tax withholdingCommon Stock | 439,919 | $69.63 | $30,631,559.97 |
DisclosureSEC source: 0001127602-20-030476 · form4.xml · nonDerivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,203,217 F1 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| November 12, 2020 Filed Nov 16, 2020 21:38 UTC | HOLOGIC INC HOLX · Entity 12463 | Tax withholdingCommon Stock | 8,179 | $70.20 | $574,165.80 |
DisclosureSEC source: 0001127602-20-029145 · form4.xml · nonDerivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,643,136 F1 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| November 11, 2020 Filed Nov 12, 2020 22:51 UTC | HOLOGIC INC HOLX · Entity 12463 | Tax withholdingCommon Stock | 7,633 | $69.84 | $533,088.72 |
DisclosureSEC source: 0001127602-20-028871 · form4.xml · nonDerivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,651,315 F3 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| November 09, 2020 Filed Nov 12, 2020 22:51 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantNon-qualified Stock Option (Right to Buy) · Derivative | 123,801 | $0.00 Strike: $68.35 | $0.00 |
DisclosureSEC source: 0001127602-20-028871 · form4.xml · derivative · entry 3 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,801 Underlying: Common Stock · 123,801 shares Expires 2030-11-09 F4 · derivative.exercise_date: This option to purchase common stock becomes exercisable in equal installments on each of the first four anniversaries of the grant date, November 9, 2020. Read SEC document |
| November 09, 2020 Filed Nov 12, 2020 22:51 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantCommon Stock | 36,199 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-028871 · form4.xml · nonDerivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,658,948 F1 · shares: Represents restricted stock units which vest in equal installments on each of the first three anniversaries of the grant date, November 9, 2020. F2 · price: Restricted stock units are settled in shares of common stock on a one-for-one basis. F3 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 22:44 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantCommon Stock | 900,307 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-028190 · form4.xml · nonDerivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,622,749 F1 · shares: Represents performance stock units as to which the performance criteria has been satisfied but which remain subject to service-based vesting requirements. F2 · price: Performance stock units are settled in shares of common stock on a one-for-one basis. F3 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| October 01, 2020 Filed Oct 5, 2020 20:31 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | GrantCommon Stock | 498 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-012182 · doc4.xml · nonDerivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 F1 · shares: Restricted stock granted in lieu of cash compensation, vesting in full upon the next annual meeting of stockholders. Reflects a value of $19,167, divided by the closing price of common stock on the date of grant. This grant represents the equivalent of two months of the board cash retainer as a result of board approval of the restoration of a portion of its cash compensation as disclosed on a Form 8-K dated October 5, 2020. Read SEC document |
| May 13, 2020 Filed May 15, 2020 20:17 UTC | HOLOGIC INC HOLX · Entity 12463 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 215,996 | $0.00 Strike: $22.29 | $0.00 |
DisclosureSEC source: 0001127602-20-016754 · form4.xml · derivative · entry 3 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 215,996 shares Expires 2020-12-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 13, 2020 Filed May 15, 2020 20:17 UTC | HOLOGIC INC HOLX · Entity 12463 | SaleCommon Stock | 190,996 | $50.97 | $9,735,257.12 |
DisclosureSEC source: 0001127602-20-016754 · form4.xml · nonDerivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,722,442 F2 · price: The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranges from $50.47 to $51.415 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price. F1 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| May 13, 2020 Filed May 15, 2020 20:17 UTC | HOLOGIC INC HOLX · Entity 12463 | Exercise / conversionCommon Stock | 215,996 | $22.29 | $4,814,550.84 |
DisclosureSEC source: 0001127602-20-016754 · form4.xml · nonDerivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,913,438 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| May 07, 2020 Filed May 11, 2020 20:43 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | GrantCommon Stock | 1,554 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-007403 · doc4.xml · nonDerivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,502 F2 · shares: Restricted stock granted in lieu of 100% of cash compensation, vesting in full upon the next annual meeting of stockholders. Reflects a value of $57,500, divided by the closing price of common stock on the date of grant. Read SEC document |
| May 07, 2020 Filed May 11, 2020 20:43 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-007403 · doc4.xml · nonDerivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,948 F1 · shares: Annual equity award in the form of restricted stock vesting in full upon the next annual meeting of stockholders. Reflects a value of $185,000 divided by the closing price of common stock on the date of grant. Read SEC document |
| May 06, 2020 Filed Oct 20, 2021 20:29 UTC | HOLOGIC INC HOLX · Entity 12463 | GiftCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-027388 · form5.xml · nonDerivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,188,217 F1 · kind: Transaction code should read "G5". F2 · kind: The transactions reported represent gifts by the reporting person to create and fund Davidson College's first fully endowed athletic scholarship program. F3 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| February 03, 2020 Filed Feb 5, 2020 21:16 UTC | HOLOGIC INC HOLX · Entity 12463 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 215,996 | $0.00 Strike: $22.29 | $0.00 |
DisclosureSEC source: 0001127602-20-003742 · form4.xml · derivative · entry 3 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,996 Underlying: Common Stock · 215,996 shares Expires 2020-12-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction pursuant to an existing Rule 10b5-1 trading plan, which plan was described in the Form 8-K filed by Hologic on June 4, 2019. Read SEC document |
| February 03, 2020 Filed Feb 5, 2020 21:16 UTC | HOLOGIC INC HOLX · Entity 12463 | SaleCommon Stock | 194,396 | $53.54 | $10,407,184.26 |
DisclosureSEC source: 0001127602-20-003742 · form4.xml · nonDerivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,697,442 F1 · kind: Transaction pursuant to an existing Rule 10b5-1 trading plan, which plan was described in the Form 8-K filed by Hologic on June 4, 2019. F3 · price: The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $53.295 to $54.160 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price. F2 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| February 03, 2020 Filed Feb 5, 2020 21:16 UTC | HOLOGIC INC HOLX · Entity 12463 | Exercise / conversionCommon Stock | 215,996 | $22.29 | $4,814,550.84 |
DisclosureSEC source: 0001127602-20-003742 · form4.xml · nonDerivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,891,838 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction pursuant to an existing Rule 10b5-1 trading plan, which plan was described in the Form 8-K filed by Hologic on June 4, 2019. F2 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| December 03, 2019 Filed Dec 3, 2019 21:45 UTC | HOLOGIC INC HOLX · Entity 12463 | OtherCommon Stock | 13,716 | $51.69 | $708,980.04 |
DisclosureSEC source: 0001127602-19-034157 · form4.xml · nonDerivative · entry 3 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,675,842 F2 · kind: Shares transferred pursuant to marriage settlement agreement. F3 · price: Closing price per share of Hologic stock on December 3, 2019. F1 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| December 01, 2019 Filed Dec 3, 2019 21:45 UTC | HOLOGIC INC HOLX · Entity 12463 | Tax withholdingCommon Stock | 8,387 | $51.32 | $430,420.84 |
DisclosureSEC source: 0001127602-19-034157 · form4.xml · nonDerivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,689,558 F1 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| December 01, 2019 Filed Dec 3, 2019 21:45 UTC | HOLOGIC INC HOLX · Entity 12463 | Tax withholdingCommon Stock | 4,772 | $51.32 | $244,899.04 |
DisclosureSEC source: 0001127602-19-034157 · form4.xml · nonDerivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,697,945 F1 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| November 12, 2019 Filed Nov 13, 2019 22:31 UTC | HOLOGIC INC HOLX · Entity 12463 | Tax withholdingCommon Stock | 8,178 | $46.15 | $377,414.70 |
DisclosureSEC source: 0001127602-19-032652 · form4.xml · nonDerivative · entry 8 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,702,717 F7 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| November 11, 2019 Filed Nov 13, 2019 22:31 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantNon-qualified Stock Option (Right to Buy) · Derivative | 152,529 | $0.00 Strike: $45.61 | $0.00 |
DisclosureSEC source: 0001127602-19-032652 · form4.xml · derivative · entry 11 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,529 Underlying: Common Stock · 152,529 shares Expires 2029-11-11 F11 · derivative.exercise_date: This option to purchase common stock becomes exercisable in equal installments on each of the first four anniversaries of the grant date, November 11, 2019. Read SEC document |
| November 11, 2019 Filed Nov 13, 2019 22:31 UTC | HOLOGIC INC HOLX · Entity 12463 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 21,600 | $0.00 Strike: $22.29 | $0.00 |
DisclosureSEC source: 0001127602-19-032652 · form4.xml · derivative · entry 10 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 431,992 Underlying: Common Stock · 21,600 shares Expires 2020-12-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction pursuant to an existing Rule 10b5-1 trading plan, which plan was described in the Form 8-K filed by Hologic on June 4, 2019. Read SEC document |
| November 11, 2019 Filed Nov 13, 2019 22:31 UTC | HOLOGIC INC HOLX · Entity 12463 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 194,396 | $0.00 Strike: $22.29 | $0.00 |
DisclosureSEC source: 0001127602-19-032652 · form4.xml · derivative · entry 9 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 453,592 Underlying: Common Stock · 194,396 shares Expires 2020-12-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction pursuant to an existing Rule 10b5-1 trading plan, which plan was described in the Form 8-K filed by Hologic on June 4, 2019. Read SEC document |
| November 11, 2019 Filed Nov 13, 2019 22:31 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantCommon Stock | 21,925 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-032652 · form4.xml · nonDerivative · entry 7 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,710,895 F10 · shares: Represents matching restricted stock units granted to the Reporting Person which vest in one installment on the third anniversary of the grant date, November 11, 2019. F9 · price: Restricted stock units are settled in shares of common stock on a one-for-one basis. F7 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| November 11, 2019 Filed Nov 13, 2019 22:31 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantCommon Stock | 46,183 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-032652 · form4.xml · nonDerivative · entry 6 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,688,970 F8 · shares: This restricted stock unit award vests in three equal installments beginning on the first anniversary of the grant date, November 11, 2019. F9 · price: Restricted stock units are settled in shares of common stock on a one-for-one basis. F7 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| November 11, 2019 Filed Nov 13, 2019 22:31 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantCommon Stock | 33,772 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-032652 · form4.xml · nonDerivative · entry 5 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,642,787 F5 · shares: Represents performance stock units as to which the performance criteria has been satisfied but which remain subject to service-based vesting requirements. Once vested, the settlement of these performance stock units will be deferred pursuant to Issuer's Deferred Equity Plan. F6 · price: Performance stock units are settled in shares of common stock on a one-for-one basis. F7 · balance_after: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| November 11, 2019 Filed Nov 13, 2019 22:31 UTC | HOLOGIC INC HOLX · Entity 12463 | Exercise / conversionCommon Stock | 21,600 | $22.29 | $481,464.00 |
DisclosureSEC source: 0001127602-19-032652 · form4.xml · nonDerivative · entry 4 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,609,015 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction pursuant to an existing Rule 10b5-1 trading plan, which plan was described in the Form 8-K filed by Hologic on June 4, 2019. F2 · balance_after: Includes 1,045,901 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.